Oncoimmunology
![Oncoimmunology](/sites/default/files/styles/cabecera_1920x900/public/imagenes/unidades/inmunomodulacion.jpg?itok=84S4LKyK)
The Oncoimmunology Research Unit develops gene vaccines for cancer treatment. It analyses their effects in inhibitory cells of the immune system, such as myeloid-derived suppressor cells, which appear in cancer patients and favour tumour progression and metastasis. The team have shown that treatment with a lentiviral vector that expresses an immunostimulating cytokine, a PD-L1 silencing microRNA and a tumour antigen inhibits the function of myeloid-derived suppressor cells and is effective against melanoma.
![](/sites/default/files/imagenes/360/360_INMUNOMODULACION_logo.jpg)
![Día Mundial contra el Cáncer](/sites/default/files/imagenes/videos/videoaecc2022.jpg)
Navarrabiomed - Centro de investigación biomédica
Complejo Hospitalario de Navarra, edificio de investigación.
Calle Irunlarrea, 3. 31008 Pamplona, Navarra, España.